(Q81706493)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Gerhard Opelz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Collaborative Transplant Study

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

9470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1570-1576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

Slow release salbutamol and Tedral in the treatment of reversible airways obstruction

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Microdroplet Assay of Human Serum Cytotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Epitope specificity of HLA class I alloantibodies I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Kidney transplant recipients with long incubation-positive antiglobulin-negative T cell crossmatches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

The relevance of a more sensitive crossmatch assay to renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Nomenclature for factors of the HLA system, 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Pretransplant lymphocytotoxins and bone-marrow graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Minor H antigens: genes and peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Kidney graft failure and presensitization against HLA class I and class II antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

Soluble HLA antigens and ELISA--a new technology for crossmatch testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966458-6

7 January 2021

10.1016/S0140-6736(05)66458-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866311%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference